Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 15, Issue 2, Pages 60-65Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2004.01.006
Keywords
-
Categories
Ask authors/readers for more resources
Parathyroid hormone (PTH) is the major hormone regulating calcium metabolism. It is also the only FDA-approved drug for osteoporosis treatment that stimulates bone formation when injected daily. However, continuous infusion of PTH causes severe bone loss in line with its known catabolic effects. Many studies to understand the dual effects of PTH have been carried out, and in recent years a growing number of molecular and cellular mechanisms underlying these effects have emerged. Here, we outline the present knowledge and conclude that the kinetics of administration and subsequent signaling probably account for the divergent actions of the hormone.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available